Cadila Healthcare reports 15% fall in Q4 consolidated net profit

22 Jun 2020 Evaluate

Cadila Healthcare has reported results for the fourth quarter and year ended March 31, 2020.

The company has reported 2 - fold jumps in its net profit of Rs 619.30 crore for the quarter under review as compared to Rs 242.20 crore for the same quarter in the previous year. Total income of the company increased by 37.74% at Rs 2212.40 crore for Q4FY20 as compared Rs 1606.20 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported 14.82% fall in its net profit of Rs 391.90 crore for the quarter under review as against Rs 460.10 crore for the same quarter in the previous year. However, total income of the company increased by 0.67% at Rs 3796.40 crore for Q4FY20 as compared Rs 3771.20 crore for the corresponding quarter previous year.

For the year ended March 31, 2020, the company has reported a 4.90% fall in its net profit of Rs 1412.90 crore as compared to Rs 1485.70 crore for the previous year. However, total income of the company increased by 9.10% at Rs 7196.80 crore for year under review as compared to Rs 6596.70 crore for year ended March 31, 2019.

For the year ended March 31, 2020, on the consolidated basis, the company has reported a 36.36% fall in its net profit of Rs 1176.60 crore as compared to Rs 1848.80 crore for the previous year. However, total income of the company increased by 7.48% at Rs 14367.00 crore for year under review as compared to Rs 13366.70 crore for year ended March 31, 2019.

Zydus Lifesciences Share Price

923.90 2.65 (0.29%)
16-Dec-2025 10:06 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1781.50
Dr. Reddys Lab 1273.50
Cipla 1500.40
Zydus Lifesciences 923.90
Lupin 2089.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×